Response: Further examination of intravascular hemolysis (IVH) following intravenous anti-D for immune thrombocytopenic purpura (ITP)
Author:
- Ann Reed GainesAGAnn Reed Gaines
- 15 June 2007
- journal article
- Published by American Society of Hematology in Blood
- Vol. 109 (12) , 5528
Abstract
Tarantino and colleagues, remind us of the need to further examine the frequency, pathophysiology, and prevention of serious complications of acute hemolysis associated with Rho(D) immune globulin intravenous (WinRho) treatment of immune thrombocytopenic purpura (ITP). Complications reported to dateKeywords
This publication has 14 references indexed in Scilit:
- Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rho(D) immune globulin intravenous administration for immune thrombocytopenic purpuraBlood, 2005
- Anti-D immune globulin: protecting platelets at a costBlood, 2005
- Characterization of mutations in severe methylenetetrahydrofolate reductase deficiency reveals an FAD-responsive mutationHuman Mutation, 2003
- Effect of riboflavin supplementation on plasma homocysteine in elderly people with low riboflavin statusEuropean Journal of Clinical Nutrition, 2002
- Methylenetetrahydrofolate reductase: a link between folate and riboflavin?The American Journal of Clinical Nutrition, 2002
- High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km): relevance to genetic disease and polymorphismsThe American Journal of Clinical Nutrition, 2002
- Genetic diversity and disease: Opportunities and challengeProceedings of the National Academy of Sciences, 2001
- Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductaseProceedings of the National Academy of Sciences, 2001
- Detection of multiple passively acquired alloantibodies following infusions of IV Rh immune globulinTransfusion, 2000
- Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rho(D) immune globulin intravenous administration in immune thrombocytopenic purpura patientsBlood, 2000